{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T09:56:31Z","timestamp":1783850191320,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cell Biology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejcb.2011.04.001","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T08:16:20Z","timestamp":1308471380000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Virus-specific T cells for therapy \u2013 Approaches, problems, solutions"],"prefix":"10.1016","volume":"91","author":[{"given":"Andreas","family":"Moosmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hammerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Jochem","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejcb.2011.04.001_bib0005","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy","volume":"2","author":"Adhikary","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"Adhikary","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nm.2128","article-title":"Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy","volume":"16","author":"Bendle","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1600-6143.2009.02672.x","article-title":"Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy","volume":"9","author":"Brestrich","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0030","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.0.CO;2-C","article-title":"Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion","volume":"29","author":"Brosterhus","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0045","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1182\/blood.V99.7.2592","article-title":"Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication","volume":"99","author":"Comoli","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00007890-199502270-00015","article-title":"An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation","volume":"59","author":"Cox","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0055","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0060","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.4049\/jimmunol.169.6.3257","article-title":"NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation","volume":"169","author":"Falk","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0070","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp-65 specific T-cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V97.4.835","article-title":"An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs","volume":"97","author":"Gottschalk","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0075","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0085","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0090","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/sj.gt.3302714","article-title":"Genetic design of an optimized packaging cell line for gene vectors transducing human B cells","volume":"13","author":"Hettich","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0100","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0110","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1073\/pnas.96.18.10391","article-title":"Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease","volume":"96","author":"Khanna","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0115","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2007-06-095414","article-title":"Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells","volume":"110","author":"Klenovsek","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nm0602-631","article-title":"Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer","volume":"8","author":"Knabel","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0125","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0130","doi-asserted-by":"crossref","first-page":"17481","DOI":"10.1073\/pnas.0804788105","article-title":"Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas","volume":"105","author":"Kruschinski","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0135","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.0902155","article-title":"A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2\/neu-specific T cell repertoire","volume":"184","author":"Liang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0140","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/342385","article-title":"Ganciclovir-resistant cytomegalovirus in organ transplant recipients","volume":"35","author":"Limaye","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.beha.2006.09.003","article-title":"Risk assessment in haematopoietic stem cell transplantation: viral status","volume":"20","author":"Ljungman","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0150","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0155","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"Moosmann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0160","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V100.5.1755.h81702001755_1755_1764","article-title":"B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells","volume":"100","author":"Moosmann","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1526","article-title":"Cellular immunotherapy for viral infection after HSC transplantation","volume":"5","author":"Moss","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing","volume":"81","author":"Pappworth","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0175","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0180","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0195","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0200","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.4049\/jimmunol.0902233","article-title":"CMV-specific TCR-transgenic T cells for immunotherapy","volume":"183","author":"Schub","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/bbmt.2002.v8.pm11939601","article-title":"Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation","volume":"8","author":"Sokos","year":"2002","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0215","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1005802107","article-title":"Mixed T cell receptor dimers harbor potentially harmful neoreactivity","volume":"107","author":"van Loenen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0220","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood.V99.9.3319","article-title":"Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application","volume":"99","author":"von Bergwelt-Baildon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0225","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0230","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/eji.200425936","article-title":"Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines","volume":"35","author":"Wiesner","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejcb.2011.04.001_bib0235","doi-asserted-by":"crossref","first-page":"e1464","DOI":"10.1371\/journal.pone.0001464","article-title":"Conditional immortalization of human B cells by CD40 ligation","volume":"3","author":"Wiesner","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejcb.2011.04.001_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.humimm.2006.12.004","article-title":"Activated B cells mediate efficient expansion of rare antigen-specific T cells","volume":"68","author":"Zentz","year":"2007","journal-title":"Hum. Immunol."}],"container-title":["European Journal of Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933511000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933511000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T17:14:49Z","timestamp":1759252489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171933511000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0171933511000628"],"URL":"https:\/\/doi.org\/10.1016\/j.ejcb.2011.04.001","relation":{},"ISSN":["0171-9335"],"issn-type":[{"value":"0171-9335","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-specific T cells for therapy \u2013 Approaches, problems, solutions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejcb.2011.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}